(Q34017632)

30 July 2017

1 reference

title

Oral delivery of salmon calcitonin (English)

1 reference

30 July 2017

Y H Lee

1

1 reference

PubMed ID

10963837

30 July 2017

P J Sinko

series ordinal

2

1 reference

PubMed ID

10963837

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Advanced Drug Delivery Reviews

30 July 2017

1 reference

30 July 2017

42

1 reference

30 July 2017

3

1 reference

30 July 2017

225-238

1 reference

The role of calcitonin in the development and treatment of osteoporosis

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Pharmacology and therapeutic use of calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Correlation of calcitonin structure with chromatographic retention in high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Inactivation of Calcitonin by Specific Organs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Absorption of peptide and peptidomimetic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Effects of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Metabolism of porcine, human and salmon calcitonin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Intracolonic bioavailability of human calcitonin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Colonic absorption of human calcitonin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Compared kinetics of salmon and human radioiodinated calcitonins in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Absorption of human calcitonin across the rat colon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

The effect of rectal and nasal administration of salmon calcitonin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

A new approach to the oral administration of insulin and other peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Delivery of recombinant peptide and protein drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Studies on the stability of pancreatic enzymes in duodenal fluid to storage temperature and pH

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

[Delivery system design for improvement of intestinal absorption of peptide drugs]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

N-acylated alpha-amino acids as novel oral delivery agents for proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Temperature and pH-sensitive polymers for human calcitonin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Review: clinical opportunities provided by the nasal administration of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Plasma level monitoring of nasal salmon calcitonin in the rat by a heterogeneous two-site enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Studies of drug delivery systems for a therapeutic agent used in osteoporosis. II. Enhanced absorption of elcatonin from nasal mucosa in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900063-6

7 January 2021

10.1016/S0169-409X(00)00063-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10963837